Shawn C. Bugden

Winnipeg, MB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Safer Opioid Supply, Subsequent Drug Decriminalization, and Opioid Overdoses.

Safer Opioid Supply, Subsequent Drug Decriminalization, and Opioid Overdoses.

Journal: JAMA health forum

Published: March 21, 2025

Experiences of people who inject drugs with hepatitis C testing and their perceptions of a pharmacy-based testing option: a qualitative study.

Experiences of people who inject drugs with hepatitis C testing and their perceptions of a pharmacy-based testing option: a qualitative study.

Journal: International journal of clinical pharmacy

Published: January 14, 2025

Clearing the confounding confusion: Benzodiazepines and the risk of dementia?

Clearing the confounding confusion: Benzodiazepines and the risk of dementia?

Journal: Archives of gerontology and geriatrics

Published: September 08, 2024

British Columbia's Safer Opioid Supply Policy and Opioid Outcomes.

British Columbia's Safer Opioid Supply Policy and Opioid Outcomes.

Journal: JAMA internal medicine

Published: January 16, 2024

Association between non-medical cannabis legalization and alcohol sales: Quasi-experimental evidence from Canada.

Association between non-medical cannabis legalization and alcohol sales: Quasi-experimental evidence from Canada.

Journal: Drug and alcohol dependence

Published: October 16, 2023

Cost-effectiveness of canagliflozin and dapagliflozin for treatment of patients with chronic kidney disease and type 2 diabetes.

Cost-effectiveness of canagliflozin and dapagliflozin for treatment of patients with chronic kidney disease and type 2 diabetes.

Journal: Diabetes, obesity & metabolism

Published: March 09, 2023

Comparative efficacy of sodium-glucose co-transporter-2 inhibitors, glucagon-like peptide-1 receptor agonists and non-steroidal mineralocorticoid receptor antagonists in chronic kidney disease and type 2 diabetes: A systematic review and network meta-analysis.

Comparative efficacy of sodium-glucose co-transporter-2 inhibitors, glucagon-like peptide-1 receptor agonists and non-steroidal mineralocorticoid receptor antagonists in chronic kidney disease and type 2 diabetes: A systematic review and network meta-analysis.

Journal: Diabetes, obesity & metabolism

Published: November 02, 2022

Cost-effectiveness of dapagliflozin and empagliflozin for treatment of heart failure with reduced ejection fraction.

Cost-effectiveness of dapagliflozin and empagliflozin for treatment of heart failure with reduced ejection fraction.

Journal: International journal of cardiology

Published: September 06, 2022

Signal and Noise: Proton Pump Inhibitors and the Risk of Dementia?

Signal and Noise: Proton Pump Inhibitors and the Risk of Dementia?

Journal: Clinical pharmacology and therapeutics

Published: July 05, 2022

Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom.

Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom.

Journal: BMC endocrine disorders

Published: April 14, 2022

Potential Overtreatment and Overtesting Among Older Adults With Type 2 Diabetes Across Canada: An Observational, Retrospective Cohort Study.

Potential Overtreatment and Overtesting Among Older Adults With Type 2 Diabetes Across Canada: An Observational, Retrospective Cohort Study.

Journal: Canadian journal of diabetes

Published: June 30, 2021

Regional variation in the potentially inappropriate first-line use of fluoroquinolones in Canada as a key to antibiotic stewardship? A drug utilization review study.

Regional variation in the potentially inappropriate first-line use of fluoroquinolones in Canada as a key to antibiotic stewardship? A drug utilization review study.

Journal: BMC infectious diseases

Published: May 06, 2021

Showing 1-12 of 47

Last Updated: 09/26/2026